Home › Funds › Carlyle Group Inc. › QTTB

Carlyle Group Inc. position in QTTB

Q32 Bio Inc · Health Care

Carlyle Group Inc. reported holding 60,363 shares of QTTB (Q32 Bio Inc) in its Q2 2026 13F filing — a position valued at US$769K, representing 0.01% of its reported portfolio and ranking #13 among its reported holdings. Carlyle Group Inc. has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)60.36K sh
Reported value held$769.02K
Portfolio Weight0.01%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Carlyle Group Inc.'s QTTB position evolved

Carlyle Group Inc. first disclosed a stake in QTTB in Q1 2024 at 1,102,741 shares (US$18.1M). The position peaked in Q3 2024 at 1,102,741 shares, worth US$48.6M. Across 10 filings, Carlyle Group Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 60,363 shares valued at US$769K — a reduction of -1,042,378 shares quarter over quarter.. Notable position changes include a 95% trim in Q2 2026 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.10M $18.07M New
Q2 2024 1.10M $19.20M Hold
Q3 2024 1.10M $48.62M Hold
Q4 2024 1.10M $3.78M Hold
Q1 2025 1.10M $1.81M Hold
Q2 2025 1.10M $1.62M Hold
Q3 2025 1.10M $2.13M Hold
Q4 2025 1.10M $3.62M Hold
Q1 2026 1.10M $7.08M Hold
Q2 2026 60.36K $769.02K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QTTB and 13F data

QTTB (Q32 Bio Inc) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QTTB

All QTTB fund holders →

FAQ

How long has Carlyle Group Inc. held QTTB?

Carlyle Group Inc. has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Carlyle Group Inc.'s current position in QTTB?

As of Q2 2026, Carlyle Group Inc. holds 60.36K shares of QTTB (Q32 Bio Inc), valued at $769.02K, representing 0.01% of its reported portfolio and ranking #13.

Has Carlyle Group Inc. been buying or selling QTTB?

In the latest 13F filing (Q2 2026), Carlyle Group Inc. reduced its position in QTTB. The position peaked in Q3 2024 at 1.10M shares.

Which other funds hold QTTB?

Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.